A Prospective Observational Study to Investigate the Correlation Analysis Between Alport Syndrome and a Variety of COL4A Mutations

Status

Recruiting

Phases

Early Phase 1

Study type

Observational

Source

ChiCTR

Registry ID

ChiCTR2000039326

Enrollment

Unknown

Registered

2020-10-23

Start date

2021-01-01

Completion date

Unknown

Last updated

2021-01-25

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Alport syndrome

Interventions

case series:Nil

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: All patients with Alport syndrome and their family members admitted to West China Hospital of Sichuan University and the First Affiliated Hospital of Army Military Medical University were included in the study, regardless of gender and age. 1. Patients with hematuria and thin-sheet GBM; 2. Hearing loss with hematuria; 3. Having lens or spotted retinopathy with hematuria; 4. High-risk family members of the chain Alport syndrome family.

Exclusion criteria

Exclusion criteria: Nil

Design outcomes

Primary

Measure	Time frame
Genetic mutations;	—

Countries

China

Contacts

Public ContactYong Liao

Minda Hospital of Hubei Minzu University; West China Hospital, Sichuan University

13687100@qq.com+86 15971688795

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026